Key facts
- Camstent’s last known valuation is $8.6M (Dec 2025).
- It has raised $6.8M; the latest was Later Stage VC ($1.1M) in Dec 2025.
- Notable investors include Innovate UK, Cambridge Angels, London Business Angels, EMV Capital, Global Reach Investments — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Camstent
- ·The full record, as it builds
Funding rounds
No funding rounds for Camstent are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Camstent
Manufacturer and developer of polymer coatings designed to resist the attachment of biofilms. The company's surface coating prevents the attachment of bacteria, blood, and proteins to the surface of consumable medical devices and addresses the problem of hospital-acquired infections, enabling surgeons to avoid infections and prevent the colonization of harmful microorganisms on surfaces.
- Sector
- Materials and Resources
- HQ
- Bedford, United Kingdom
- Founded
- 2006
- Employees
- 4
- Website
- camstent.com/
- Ownership
- Privately Held (backing)
Camstent doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Camstent shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Camstent in its N-PORT filings yet. We sweep new filings monthly.